The company’s market cap is set at $1.39 billion. Market analysts have given MedAssets a consensus rating of “hold” for this week, according to the report.
The stock’s one-year high is $25.57, and its one-year low is $17.
More articles on finance issues:
CMS pitches bundled payment approach for hip, knee replacements
10 things for CFOs to know about CAUTIs
RCM tip of the day: Streamlined systems interactions
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.